Raj Denhoy
Stock Analyst at Jefferies
(3.03)
# 1,222
Out of 5,172 analysts
55
Total ratings
68.09%
Success rate
24.45%
Average return
Main Sectors:
Stocks Rated by Raj Denhoy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Reiterates: Hold | $120 | $105.46 | +13.79% | 5 | Sep 26, 2024 | |
| EW Edwards Lifesciences | Maintains: Buy | $110 → $130 | $82.50 | +57.58% | 10 | Jul 30, 2021 | |
| HOLX Hologic | Maintains: Buy | $106 → $110 | $75.41 | +45.87% | 9 | Apr 5, 2021 | |
| PROF Profound Medical | Initiates: Buy | n/a | $5.06 | - | 1 | Sep 15, 2020 | |
| DXCM DexCom | Maintains: Buy | $29 → $31 | $66.95 | -53.32% | 8 | Aug 2, 2018 | |
| AXGN Axogen | Initiates: Buy | $35 | $30.78 | +13.71% | 1 | Nov 30, 2017 | |
| TFX Teleflex | Maintains: Buy | $270 → $295 | $105.41 | +179.86% | 9 | Nov 3, 2017 | |
| LIVN LivaNova | Maintains: Buy | $80 → $91 | $62.19 | +46.33% | 3 | Nov 3, 2017 | |
| LNTH Lantheus Holdings | Maintains: Buy | $22 → $27 | $76.43 | -64.67% | 2 | Nov 3, 2017 | |
| PODD Insulet | Maintains: Buy | $58 → $67 | $227.10 | -70.50% | 7 | Nov 3, 2017 |
Abbott Laboratories
Sep 26, 2024
Reiterates: Hold
Price Target: $120
Current: $105.46
Upside: +13.79%
Edwards Lifesciences
Jul 30, 2021
Maintains: Buy
Price Target: $110 → $130
Current: $82.50
Upside: +57.58%
Hologic
Apr 5, 2021
Maintains: Buy
Price Target: $106 → $110
Current: $75.41
Upside: +45.87%
Profound Medical
Sep 15, 2020
Initiates: Buy
Price Target: n/a
Current: $5.06
Upside: -
DexCom
Aug 2, 2018
Maintains: Buy
Price Target: $29 → $31
Current: $66.95
Upside: -53.32%
Axogen
Nov 30, 2017
Initiates: Buy
Price Target: $35
Current: $30.78
Upside: +13.71%
Teleflex
Nov 3, 2017
Maintains: Buy
Price Target: $270 → $295
Current: $105.41
Upside: +179.86%
LivaNova
Nov 3, 2017
Maintains: Buy
Price Target: $80 → $91
Current: $62.19
Upside: +46.33%
Lantheus Holdings
Nov 3, 2017
Maintains: Buy
Price Target: $22 → $27
Current: $76.43
Upside: -64.67%
Insulet
Nov 3, 2017
Maintains: Buy
Price Target: $58 → $67
Current: $227.10
Upside: -70.50%